Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00094848 · ClinicalTrials.gov registry record · Phase 2
Study of TRM-1 (TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)
A Phase 2 study, sponsored by Human Genome Sciences.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00094848: Completed Phase 2 study, sponsored by Human Genome Sciences.
NCT00094848 is a Phase 2 study that has completed, run by Human Genome Sciences. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00094848, a Phase 2 study, has completed, sponsored by Human Genome Sciences.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
The purpose of this study is to evaluate the safety, efficacy and exposure to TRM-1 in subjects with relapsed or refractory Non-Hodgkin's Lymphoma (NHL).
Interventions
- DRUG TRAIL-R1 mAb (TRM-1; HGS-ETR1)
Trial Details
| Field | Value |
|---|---|
| Start Date | 2004-06 |
| Est. Completion | 2007-05 |
| Phase | Phase 2 |
What the finished NCT00094848 record still lists
NCT00094848 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which TRAIL-R1 mAb (TRM-1; HGS-ETR1) is the first listed.
NCT00094848 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00094848 about?
NCT00094848 is a clinical study titled "Study of TRM-1 (TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)". The purpose of this study is to evaluate the safety, efficacy and exposure to TRM-1 in subjects with relapsed or refractory Non-Hodgkin's Lymphoma (NHL).
What is the current status of trial NCT00094848?
This trial is currently completed. It is a Phase 2 study. The study started on 2004-06. Estimated completion is 2007-05.
What interventions are being tested in trial NCT00094848?
The interventions under investigation include: TRAIL-R1 mAb (TRM-1; HGS-ETR1) (DRUG).
Who is sponsoring clinical trial NCT00094848?
This trial is sponsored by Human Genome Sciences, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia